Şizofrenide aripiprazol kullanımı ile ilişkili mani: Bir olgu sunumu
| Autor: | Cagdas Hunkar Yeloglu, Bülent Bahçeci, Cicek Hocaoglu, Ayse Koroglu, Fatmagul Helvaci Celik |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment medicine.disease behavioral disciplines and activities Psychiatry and Mental health Hypomania Tolerability Schizophrenia mental disorders medicine Major depressive disorder Aripiprazole Neurology (clinical) Bipolar disorder medicine.symptom Psychiatry Psychology Antipsychotic Mania medicine.drug |
| Zdroj: | Dusunen Adam: The Journal of Psychiatry and Neurological Sciences. :356-358 |
| ISSN: | 1309-5749 1018-8681 |
| DOI: | 10.5350/dajpn2014270412 |
| Popis: | Mania associated with aripiprazole treatment in schizophrenia: a case report Aripiprazole is a novel antipsychotic medication that is used to treat a number of psychiatric conditions, including schizophrenia, bipolar disorder, and major depressive disorder. Clinical trials have established its efficacy and favorable tolerability profile. Nevertheless, infrequent undesirable adverse events are often encountered during wide-scale everyday clinical use. There are a few mania/hypomania cases associated with second-generation antipsychotic treatment. Induction of mania, described for almost all secondgeneration antipsychotic, may be one of the rare adverse events of aripiprazole therapy. In this study, a female patient with chronic schizophrenia who had never presented history of mood episodes, in which manic symptoms developed after increasing aripiprazole dosage to 30mg/day and disappeared after cessation of the treatment was presented. During the second-generation antipsychotic use, clinicians should be cautious to patients’s mania/hypomania symptoms. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|